|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM23122687X |
003 |
DE-627 |
005 |
20231224090232.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/la402229k
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0770.xml
|
035 |
|
|
|a (DE-627)NLM23122687X
|
035 |
|
|
|a (NLM)24073802
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Redolfi Riva, Eugenio
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a PMMA/polysaccharides nanofilm loaded with adenosine deaminase inhibitor for targeted anti-inflammatory drug delivery
|
264 |
|
1 |
|c 2013
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 21.05.2014
|
500 |
|
|
|a Date Revised 29.10.2013
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a A novel drug delivery vector, a free-standing polymeric ultrathin film (nanofilm) composed of PMMA and a polysaccharides multilayer, is presented. Chitosan and sodium alginate are alternatively deposited by spin-assisted LbL assembly onto a plasma-treated PMMA thin film. Hydrophobic anti-inflammatory drugs, an adenosine deaminase inhibitor (APP) and its fluorescent dansyl derivate (APP-Dns), are encapsulated inside the LbL multilayer using a simple casting deposition procedure. The resulting drug loaded nanofilm can be suspended in water upon dissolution of a PVA sacrificial layer. Morphological characterization of the nanofilm shows that PMMA/LbL nanofilms possess nanometric thickness (<200 nm) and very low surface roughness (1-2 nm for drug loaded nanofilms and <1 nm for blank nanofilm). Drug loaded films exhibit a diffusion controlled release mechanism following the Korsmayer-Peppas release model, confirmed by the fit of release data with a characteristic power law. Drug release is impaired through the PMMA layer, which acts effectively as a barrier for drug transport. This ultrathin polymer film can find application as a nanopatch for targeted inflammatory drug delivery to treat localized pathologies as inflammatory bowel disease
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Adenosine Deaminase Inhibitors
|2 NLM
|
650 |
|
7 |
|a Anti-Inflammatory Agents, Non-Steroidal
|2 NLM
|
650 |
|
7 |
|a Drug Carriers
|2 NLM
|
650 |
|
7 |
|a Polysaccharides
|2 NLM
|
650 |
|
7 |
|a Polymethyl Methacrylate
|2 NLM
|
650 |
|
7 |
|a 9011-14-7
|2 NLM
|
700 |
1 |
|
|a Desii, Andrea
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sartini, Stefania
|e verfasserin
|4 aut
|
700 |
1 |
|
|a La Motta, Concettina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mazzolai, Barbara
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mattoli, Virgilio
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 29(2013), 43 vom: 29. Okt., Seite 13190-7
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:29
|g year:2013
|g number:43
|g day:29
|g month:10
|g pages:13190-7
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/la402229k
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 29
|j 2013
|e 43
|b 29
|c 10
|h 13190-7
|